CD80 and ovarian carcinoma: The median concentrations of the studied proteins (BTLA, CD27, CD28 and CD80) were statistically significantly higher in serum of patients in the ovarian cancer group (group A) compared to serum concentrations in patients with benign ovarian lesions (group B).